$Hemispherx BioPharma, Inc.(HEB)$ CORRESP [Cover] - Correspondence Filed: 2018-07-31 AccNo: 0001493152-18-010725 Size: 16 KB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-14 AccNo: 0001493152-18-011876 Size: 3 MB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ EFFECT - Notice of Effectiveness Filed: 2018-08-03 AccNo: 9999999995-18-002006 Size: 1 KB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ EFFECT - Notice of Effectiveness Filed: 2018-08-03 AccNo: 9999999995-18-002005 Size: 1 KB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-08-03 AccNo: 0001493152-18-010961 Size: 457 KB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-08-03 AccNo: 0001493152-18-010955 Size: 457 KB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2018-08-03 AccNo: 0001493152-18-010950 Size: 429 KB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ 8-K - Current report Filed: 2018-08-03 AccNo: 0001493152-18-010947 Size: 49 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ DEF 14A - Other definitive proxy statements Filed: 2018-08-03 AccNo: 0001493152-18-010893 Size: 1 MB 网页链接
$Hemispherx BioPharma, Inc.(HEB)$ S-3/A [Amend] - Registration statement under Securities Act of 1933 Filed: 2018-07-31 AccNo: 0001493152-18-010720 Size: 52 KB 网页链接